LIGAND PHARMS GENERAL CVR (LGNYZ) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 65 93 sessions, August 28, 2025 to August 28, 2026
- Largest daily move
- +150% close of April 24, 2026
- 1-year change
- +46.9% closing prices, August 28, 2025 to August 28, 2026
Company Description
LGNYZ has gained 46.9% over the past year. The last closing price was $0.0514.
For FY2025, LIGAND PHARMS GENERAL CVR reported revenue of $268.1M with net income of $124.5M and diluted earnings per share of $6.13. The company operates at a net profit margin of 46.4%.
This page collects what Stock Titan holds for LGNYZ, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LIGAND PHARMS GENERAL CVR (LGNYZ) closed at $0.0514 on August 28, 2026. Over the past 12 months, the price has gained 46.9%.
LGNYZ Metrics & Rankings
Price returns through August 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
LIGAND PHARMS GENERAL CVR has filed 5 recent SEC filings, including 3 Form 4, 1 Form 144, 1 Form 8-K/A. The most recent filing was submitted on September 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LGNYZ SEC filings →
Financial Highlights
LIGAND PHARMS GENERAL CVR generated $268.1M in revenue in FY2025, operating income reached $41.0M (15.3% operating margin), and net income was $124.5M, reflecting a 46.4% net profit margin. Diluted earnings per share stood at $6.13. The company generated $49.4M in operating cash flow. With a current ratio of 22.23, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in LIGAND PHARMS GENERAL CVR (LGNYZ) currently stands at 532.5 thousand shares, up 918.7% from the previous reporting period, representing 2.7% of the shares outstanding. Since September 2025, short interest has increased by 6952.4%.
Days to Cover History
Days to cover for LIGAND PHARMS GENERAL CVR (LGNYZ) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.